MTOR and cancer: The mechanism of fisetin’s anticancer action involves apoptosis, cell cycle arrest, suppression of Akt/mechanistic target of rapamycin (mTOR) signaling pathways, activation of caspase-7 and -9, inhibition of various key enzymes, and downregulation of several genes associated with cancers [53,79].